Saffron and sleep
What 2 graded rows on saffron agree on for sleep, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Saffron page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Saffron page, with its PubMed record.
Your question
Saffron and sleep
2 rows · 483 peopleThey agree: both rows found an improvement.
- CGrade C× 1
- DGrade D× 1
- Rows
- 2
- Trials
- 2
- At least: a review without a trial count
- People
- 483
- Pooled reviews may count some twice
What the rows share
From the rowsThe best-graded row, grade C, is a meta-analysis of 431 people (2022) and found an improvement.
The rows run from 52 to 431 people, published from 2022 to 2025: 1 pooled review and 1 single study.
The rows
2 improved- CGrade CSleep quality and duration · Improved
Meta-analysis · n 431 · 2022 · Adults with insomnia complaints in 8 studies
Not stated in the abstract · Not stated in the abstract
Sleep quality (SMD 0.89, very low-quality evidence) and sleep duration (SMD 0.57, moderate-quality evidence) improved versus placebo; the reduction in insomnia severity was not significant.
- DGrade DSleep quality in older adults with sleep complaints · Improved
Pilot RCT · n 52 · 2025 · Adults aged 55–85 with self-reported sleep complaints
30 mg/day · 4 weeks
Subjective sleep quality (p = 0.02) and sleep efficiency (p = 0.04) improved versus placebo, and a home EEG sleep tracker recorded a shorter time to fall asleep (p = 0.03).